智通财经APP获悉，今海医疗科技(02225)涨超6%，截至发稿，涨5.63%，报3.845港元，成交额1041.77万港元。
消息面上，据MordorIntelligence报告指出，随着行业参与者适应不断变化的临床标准及患者需求，微创手术器械市场发展迅速。中国微创手术器械市场为全球增长最快的手术器械市场之一。医疗体系现代化、人口老龄化以及机器人、人工智能辅助成像及微创手术工具等先进技术的普及，共同推动该市场增长。报告还指出，中国微创手术器械行业2025年市场规模为17.1亿美元，预计2030年将增至26.8亿美元，复合年增长率为9.45%。
值得一提的是，近年来在内窥镜技术研发领域持续深耕，今海医疗科技取得了多项重要突破，覆盖从4K超高清内窥镜系统、3D及裸眼3D图像处理系统到4K荧光及未来多光谱超高清内窥镜系统等系列创新产品。其中，公司4K3D裸眼荧光内窥镜摄像系统拿下4K3D荧光内窥镜注册证，成为国产高端医疗设备领域的领跑者之一。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.